Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

News Post List

News digest – soaring skin cancer rates, breast milk, 5G and does eating insects really protect against cancer?

In the news this week: soaring melanoma skin cancer rates in younger adults and does eating insects really protect against cancer?

Cancer Research UK funding tops half a billion pounds

Cancer Research UK raised £540m in fundraising income in the last financial year, in one of its most successful fundraising years so far.

Skin cancer rates rocket by 45% in 10 years

Melanoma skin cancer incidence rates have soared by 45% since 2004, according to the latest figures released by Cancer Research UK.

Second breast cancer treatment combo added to England's Cancer Drugs Fund

Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision

News digest – sugary drinks, vagina bacteria, NHS info through Amazon’s Alexa and ‘War in the Blood’

In the news this week: a potential link between sugary drinks and cancer and the NHS teams up with Amazon Alexa to provide accessible health information.

Science Surgery: ‘Does cancer attack every age group?’

Cancer can affect any age group but we see many more cases in older people.

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

Santa makes an off-duty summer appearance to surprise children with cancer

Ollie, Connor & Kyna attended the Cancer Research UK kids & teens star awards party after missing out on Christmas due to treatment.

News digest – obesity, drug decisions, NHS waiting times and a cancer killing virus

In the news this week: obesity responsible for more cases of some cancers than smoking and a trio of NHS drug decisions.

One lung cancer drug receives NHS England approval, while another is rejected

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer.

Pages